Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.

Juratli TA, McCabe D, Nayyar N, Williams EA, Silverman IM, Tummala SS, Fink AL, Baig A, Martinez-Lage M, Selig MK, Bihun IV, Shankar GM, Penson T, Lastrapes M, Daubner D, Meinhardt M, Hennig S, Kaplan AB, Fujio S, Kuter BM, Bertalan MS, Miller JJ, Batten JM, Ely HA, Christiansen J, Baretton GB, Stemmer-Rachamimov AO, Santagata S, Rivera MN, Barker FG 2nd, Schackert G, Wakimoto H, Iafrate AJ, Carter SL, Cahill DP, Brastianos PK.

Acta Neuropathol. 2018 Aug 19. doi: 10.1007/s00401-018-1899-7. [Epub ahead of print]

PMID:
30123936
2.

Genotype-targeted local therapy of glioma.

Shankar GM, Kirtane AR, Miller JJ, Mazdiyasni H, Rogner J, Tai T, Williams EA, Higuchi F, Juratli TA, Tateishi K, Koerner MVA, Tummala SS, Fink AL, Penson T, Schmidt SP, Wojtkiewicz GR, Baig A, Francis JM, Rinne ML, Batten JM, Batchelor TT, Brastianos PK, Curry WT Jr, Barker FG 2nd, Jordan JT, Iafrate AJ, Chi AS, Lennerz JK, Meyerson M, Langer R, Wakimoto H, Traverso G, Cahill DP.

Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8388-E8394. doi: 10.1073/pnas.1805751115. Epub 2018 Aug 6.

PMID:
30082399
3.

TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study.

Juratli TA, Stasik S, Zolal A, Schuster C, Richter S, Daubner D, Juratli MA, Thowe R, Hennig S, Makina M, Meinhardt M, Lautenschlaeger T, Schackert G, Krex D, Thiede C.

Clin Cancer Res. 2018 Jun 25. doi: 10.1158/1078-0432.CCR-17-3717. [Epub ahead of print]

PMID:
29941484
4.

IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy.

Uckermann O, Yao W, Juratli TA, Galli R, Leipnitz E, Meinhardt M, Koch E, Schackert G, Steiner G, Kirsch M.

J Neurooncol. 2018 May 14. doi: 10.1007/s11060-018-2883-8. [Epub ahead of print]

PMID:
29761368
5.

A Systematic Review of the Semi-Sitting Position in Neurosurgical Patients with Patent Foramen Ovale: How Frequent Is Paradoxical Embolism?

Klein J, Juratli TA, Weise M, Schackert G.

World Neurosurg. 2018 Jul;115:196-200. doi: 10.1016/j.wneu.2018.04.114. Epub 2018 Apr 26. Review.

PMID:
29704690
6.

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas.

Juratli TA, Thiede C, Koerner MVA, Tummala SS, Daubner D, Shankar GM, Williams EA, Martinez-Lage M, Soucek S, Robel K, Penson T, Krause M, Appold S, Meinhardt M, Pinzer T, Miller JJ, Krex D, Ely HA, Silverman IM, Christiansen J, Schackert G, Wakimoto H, Kirsch M, Brastianos PK, Cahill DP.

Oncotarget. 2017 Nov 24;8(65):109228-109237. doi: 10.18632/oncotarget.22650. eCollection 2017 Dec 12.

7.

Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the IDH1 Mutation Status.

Uckermann O, Juratli TA, Galli R, Conde M, Wiedemuth R, Krex D, Geiger K, Temme A, Schackert G, Koch E, Steiner G, Kirsch M.

Clin Cancer Res. 2018 Jun 1;24(11):2530-2538. doi: 10.1158/1078-0432.CCR-17-1795. Epub 2017 Dec 19.

PMID:
29259030
8.

Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas.

Juratli TA, Qin N, Cahill DP, Filbin MG.

Pharmacol Ther. 2018 Feb;182:70-79. doi: 10.1016/j.pharmthera.2017.08.006. Epub 2017 Aug 19. Review.

PMID:
28830841
9.

Probabilistic Tractography of the Cranial Nerves in Vestibular Schwannoma.

Zolal A, Juratli TA, Podlesek D, Rieger B, Kitzler HH, Linn J, Schackert G, Sobottka SB.

World Neurosurg. 2017 Nov;107:47-53. doi: 10.1016/j.wneu.2017.07.102. Epub 2017 Jul 25.

PMID:
28754643
10.

Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma.

Klein J, Juratli TA, Radev Y, Daubner D, Soucek S, Schackert G, Krex D.

Oncology. 2017;93(1):43-50. doi: 10.1159/000464464. Epub 2017 Apr 11.

PMID:
28395288
11.

[Chronic subdural hematoma in the elderly].

Juratli TA, Klein J, Schackert G.

Chirurg. 2017 Feb;88(2):131-135. doi: 10.1007/s00104-016-0343-6. Review. German.

PMID:
28054113
12.

Comparison of probabilistic and deterministic fiber tracking of cranial nerves.

Zolal A, Sobottka SB, Podlesek D, Linn J, Rieger B, Juratli TA, Schackert G, Kitzler HH.

J Neurosurg. 2017 Sep;127(3):613-621. doi: 10.3171/2016.8.JNS16363. Epub 2016 Dec 16.

PMID:
27982771
13.

Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.

Strickland MR, Gill CM, Nayyar N, D'Andrea MR, Thiede C, Juratli TA, Schackert G, Borger DR, Santagata S, Frosch MP, Cahill DP, Brastianos PK, Barker FG 2nd.

J Neurosurg. 2017 Aug;127(2):438-444. doi: 10.3171/2016.8.JNS161076. Epub 2016 Nov 25.

PMID:
27885953
14.

Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow Cytometry.

Juratli MA, Menyaev YA, Sarimollaoglu M, Siegel ER, Nedosekin DA, Suen JY, Melerzanov AV, Juratli TA, Galanzha EI, Zharov VP.

PLoS One. 2016 May 26;11(5):e0156269. doi: 10.1371/journal.pone.0156269. eCollection 2016.

15.

[Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases].

Perrakis A, Juratli TA, Hohenberger W, Croner RS, Schackert G.

Chirurg. 2016 Mar;87(3):208-15. doi: 10.1007/s00104-015-0147-0. Review. German.

PMID:
26857002
16.

Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.

Zolal A, Juratli TA, Linn J, Podlesek D, Sitoci Ficici KH, Kitzler HH, Schackert G, Sobottka SB, Rieger B, Krex D.

J Neurooncol. 2016 May;127(3):551-7. doi: 10.1007/s11060-016-2063-7. Epub 2016 Jan 30.

PMID:
26830088
17.

[Neuroradiological diagnosis and treatment of spontaneous intracranial hypotension].

Daubner D, Juratli TA, Engellandt K, Kitzler HH, Linn J.

Rofo. 2016 Feb;188(2):119-22. doi: 10.1055/s-0041-104200. Epub 2016 Jan 27. German. No abstract available.

PMID:
26815119
18.

Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases.

Harter PN, Bernatz S, Scholz A, Zeiner PS, Zinke J, Kiyose M, Blasel S, Beschorner R, Senft C, Bender B, Ronellenfitsch MW, Wikman H, Glatzel M, Meinhardt M, Juratli TA, Steinbach JP, Plate KH, Wischhusen J, Weide B, Mittelbronn M.

Oncotarget. 2015 Dec 1;6(38):40836-49. doi: 10.18632/oncotarget.5696.

19.

Peripheral nerve field stimulation for trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain.

Klein J, Sandi-Gahun S, Schackert G, Juratli TA.

Cephalalgia. 2016 Apr;36(5):445-53. doi: 10.1177/0333102415597526. Epub 2015 Jul 24.

PMID:
26209705
20.

[Neurofibromatosis type 1 associated spinal arteriovenous fistula - treatment with primary endovascular coiling].

Daubner D, Mucha D, Juratli TA, Leimert M, Gerber JC.

Rofo. 2015 Dec;187(12):1130-2. doi: 10.1055/s-0035-1553147. Epub 2015 Jun 17. German. No abstract available.

PMID:
26085178
21.

A five year-old child with clear cell petro-clival meningioma: case report with clinical and histopathological long-term follow-up.

Juratli TA, Geiger KD, Weigel P, von der Hagen M, Daubner D, Pinzer T, Hahn G, Schackert G, Kirsch M.

Childs Nerv Syst. 2015 Nov;31(11):2193-8. doi: 10.1007/s00381-015-2782-7. Epub 2015 Jun 16.

PMID:
26077595
22.

Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients.

Juratli TA, Lautenschläger T, Geiger KD, Pinzer T, Krause M, Schackert G, Krex D.

J Neurooncol. 2015 Sep;124(2):197-205. doi: 10.1007/s11060-015-1822-1. Epub 2015 Jun 2.

PMID:
26033545
23.

Determining optimal treatment strategy for diffuse glioma: the emerging role of IDH mutations.

Juratli TA, Cahill DP, McCutcheon IE.

Expert Rev Anticancer Ther. 2015 Jun;15(6):603-6. doi: 10.1586/14737140.2015.1047351. Epub 2015 May 17.

24.

[Acute treatment of patients with severe traumatic brain injury].

Juratli TA, Stephan SE, Stephan AE, Sobottka SB.

Anaesthesist. 2015 Feb;64(2):159-74. doi: 10.1007/s00101-014-2337-4. Review. German.

PMID:
25608499
25.

Percutaneous pedicle screw and rod fixation with TLIF in a series of 14 patients with recurrent lumbar disc herniation.

Niesche M, Juratli TA, Sitoci KH, Neidel J, Daubner D, Schackert G, Leimert M.

Clin Neurol Neurosurg. 2014 Sep;124:25-31. doi: 10.1016/j.clineuro.2014.06.020. Epub 2014 Jun 23.

PMID:
24999541
26.

Early hemorrhagic progression of traumatic brain contusions: frequency, correlation with coagulation disorders, and patient outcome: a prospective study.

Juratli TA, Zang B, Litz RJ, Sitoci KH, Aschenbrenner U, Gottschlich B, Daubner D, Schackert G, Sobottka SB.

J Neurotrauma. 2014 Sep 1;31(17):1521-7. doi: 10.1089/neu.2013.3241. Epub 2014 Jul 8.

PMID:
24738836
27.

[Differential diagnoses of brain tumors around the forth ventricle].

Juratli TA, Daubner D, Engellandt K, von Kummer R, Hahn G, Schackert G, Pinzer T.

Rofo. 2014 Jan;186(1):1-4. doi: 10.1055/s-0033-1346862. Epub 2013 Dec 20. German. No abstract available.

PMID:
24363226
28.

Is there pseudoprogression in secondary glioblastomas?

Juratli TA, Engellandt K, Lautenschlaeger T, Geiger KD, von Kummer R, Cerhova J, Chakravarti A, Krex D, Schackert G.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1094-9. doi: 10.1016/j.ijrobp.2013.09.036.

29.

An extremely rare, remote intracerebral metastasis of oral cavity cancer: a case report.

Leimert M, Juratli TA, Lindner C, Geiger KD, Gerber J, Schackert G, Kirsch M.

Case Rep Med. 2013;2013:257046. doi: 10.1155/2013/257046. Epub 2013 Oct 7.

30.

Atypical Central Neurocytoma with Recurrent Spinal Dissemination over a Period of 20 Years: A Case Report and Review of the Literature.

Juratli TA, Geiger K, Leimert M, Schackert G, Kirsch M.

Case Rep Neurol Med. 2013;2013:925647. doi: 10.1155/2013/925647. Epub 2013 Jun 9.

31.

[Differential Diagnosis of Intrasellar and Suprasellar Neoplasia ].

Daubner D, Juratli TA, Engellandt K, von Kummer R, Hahn G, Schackert G, Pinzer T.

Rofo. 2013 Jun;185(6):515-20. doi: 10.1055/s-0032-1319443. Epub 2013 Jun 5. German. No abstract available.

PMID:
23740700
32.

Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.

Juratli TA, Schackert G, Krex D.

Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18. Review.

PMID:
23694764
33.

Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas.

Juratli TA, Peitzsch M, Geiger K, Schackert G, Eisenhofer G, Krex D.

Neuro Oncol. 2013 Jun;15(6):682-90. doi: 10.1093/neuonc/not006. Epub 2013 Feb 14.

34.

A newly developed drill with a polished tip for the anterior cervical approach in spinal canal stenosis: a technical note.

Leimert M, Bostelmann R, Juratli TA, Mikulin HD, Herrmann B, Schackert G, Reitemeier B.

Eur Spine J. 2013 Apr;22(4):809-12. doi: 10.1007/s00586-012-2572-9. Epub 2012 Nov 22.

35.

[Rupture of an intracranial mature teratoma].

Daubner D, Juratli TA, Engellandt K.

Rofo. 2013 Jan;185(1):71-3. doi: 10.1055/s-0032-1313212. Epub 2012 Sep 21. German. No abstract available. Erratum in: Rofo. 2013 Jan;185(1):E2.

PMID:
23023226
36.

The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas.

Juratli TA, Kirsch M, Geiger K, Klink B, Leipnitz E, Pinzer T, Soucek S, Schrock E, Schackert G, Krex D.

J Neurooncol. 2012 Dec;110(3):325-33. doi: 10.1007/s11060-012-0977-2. Epub 2012 Sep 27. Erratum in: J Neurooncol. 2013 Jan;111(1):95. Schrok, E [corrected to Schrock, E].

PMID:
23015095
37.

IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas.

Juratli TA, Kirsch M, Robel K, Soucek S, Geiger K, von Kummer R, Schackert G, Krex D.

J Neurooncol. 2012 Jul;108(3):403-10. doi: 10.1007/s11060-012-0844-1. Epub 2012 Mar 13.

PMID:
22410704

Supplemental Content

Loading ...
Support Center